A lawsuit filed by the Pharmaceutical Research and Manufacturers of America, which claims the Inflation Reduction Act’s Medicare Drug Price Negotiation Program is unconstitutional, now goes back to a lower Texas court after the U.S. Court of Appeals for the Fifth Circuit on Friday reversed a dismissal order from the district court earlier this year.
